Home›Articles›One small trial, accelerated approval and the 2026 withdrawal of TazverikArticleOne small trial, accelerated approval and the 2026 withdrawal of TazverikArticlesConnectionsSourcesComments (0)Reader Challenges (0)ConnectionsArticle OnTazemetostat, Drugs and Medicinal Substances Well-attested SourcesTazemetostat (Wikipedia)HistoryQuote, HistoryIpsen cited the advice from the data monitoring committee who observed adverse events of secondary hematologic malignancies in the SYMPHONY-1 study.View the SourceMedicine Atlas Original Articlestier 1Comments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.